Wave Life Sciences to Present Preclinical Data Supporting Therapeutic Potential of WVE-007 for Obesity at ObesityWeek® 2025
Correcting and Replacing Wave Life Sciences Announced Positive Target Engagement Data from INLIGHT Clinical Trial of WVE-007 for Obesity During Annual Research Day
Wave Life Sciences Announced Positive Target Engagement Data from INLIGHT Clinical Trial of WVE-007 for Obesity During Annual Research Day
Wave Life Sciences Announces Virtual Research Day on October 29th and Participation at Upcoming Investor Conferences
Wave Life Sciences Announces Positive Update from Ongoing RestorAATion-2 Trial of WVE-006 in Alpha-1 Antitrypsin Deficiency
SAGA Metals Completes Phase 1 & Commences Phase 2 of Drilling at Radar Project in Labrador-Confirms Extensive Oxide Mineralization Over 1.5 Km & Provides Corporate Update
Nine Mile Metals Announces Completion of DDH WD-25-02 and Continues to Confirm (2) Zones of Copper Rich VMS Mineralization at the Wedge Project Drill Program
